Kymera Therapeutics, Inc.
KYMR
Pozycja w akcjach
#2147
Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to... Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and developing pioneering small molecule therapeutics. These treatments operate by harnessing the body's inherent protein degradation system to selectively eliminate disease-causing proteins. The company's pipeline features several programs, including the IRAK4 program, currently in Phase I clinical trials, which targets various immunology-inflammation disorders such as hidradenitis suppurativa, atopic dermatitis, macrophage activation syndrome, generalized pustular psoriasis, and rheumatoid arthritis. Additionally, Kymera is advancing its IRAKIMiD program, designed to address MYD88-mutated diffuse large B cell lymphoma. Other key programs include the STAT3 program, focused on hematological malignancies, solid tumors, autoimmune diseases, and fibrosis, as well as the MDM2 program, which is also aimed at hematological malignancies and solid tumors. The company was founded in 2015 and maintains its headquarters in Watertown, Massachusetts.
Cena akcji
$113.68
Ostatnia synchronizacja: 2026-10-21
Kapitalizacja rynkowa
$9.35B
Zmiana (1 dzień)
0.19%
Zmiana (1 rok)
103.73%
Kraj
US
Handel Kymera Therapeutics, Inc. (KYMR)
Kategoria
Healthcare
Historia ceny akcji dla Kymera Therapeutics, Inc. (KYMR)
Najwyższa cena zamknięcia: $109.14 dnia 2026-10-01
Najniższa cena zamknięcia: $31.67 dnia 2020-08-01
Najniższa cena zamknięcia: $31.67 dnia 2020-08-01
Historia cen akcji firmy Kymera Therapeutics, Inc. od 2020 do 2026
Roczna wydajność ceny akcji
| Rok | Wydajność |
|---|---|
| 2026 (TTM) | 12.05% |
| 2025 | 87.59% |
| 2024 | 77.01% |
| 2023 | -11.39% |
| 2022 | -52.05% |
| 2021 | -12.80% |
| 2020 | 0.00% |
Cena akcji podobnych firm lub konkurencji
| Firma | Cena akcji | Zmiana 1r% | Kraj |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $758.21 | 7.77% |
CH
|
